Tirzepatide Study Now Enrolling Participants With Psoriatic Arthritis

You may qualify for a local clinical research study involving Tirzepatide, a medication being evaluated for its potential impact on inflammation and weight loss.

Compensation Available for Qualified Participants

Call Now: (832) 924-2863

Now Enrolling

Houston Residents

Fill out the short form below to see if you qualify — our staff will follow up. 2-3 Months On Taltz Is Necessary

By checking this box, you are agreeing to receive text messages from our company.
By checking this box, you are agreeing to receive text messages from our company.

You may be eligible if you:

  • Have been diagnosed with Psoriatic Arthritis
  • Have not previously taken Tirzepatide or other weight loss medications
  • Are seeking non-surgical options to manage inflammation and weight

This is a no-cost opportunity to contribute to future advancements in rheumatology care — and get support along the way.

Why Tirzepatide?

Tirzepatide is a promising investigational medication originally developed for weight management and type 2 diabetes. Researchers are now studying its potential benefits for autoimmune and inflammatory conditions — including Psoriatic Arthritis.


In some cases, weight reduction may also support symptom improvement and joint health.

About the Study & Dr. Brionez

Led by board-certified rheumatologist Dr. Tamar Brionez, our clinic brings over a decade of experience treating complex autoimmune and musculoskeletal conditions. You’ll receive care in a professional, supportive environment dedicated to advancing research and improving quality of life.

Located at: 10857 Kuykendahl Rd, Suite 160, Spring, TX 77382
Questions? Call (832) 924-2863 or email info@advancedrheum.com

Request More Info

Are You Living with Psoriatic Arthritis?

You may qualify for a local clinical research study involving Tirzepatide, a medication being evaluated for its potential impact on inflammation and weight loss.